Overdose Prevention Built Into Diversion: Naloxone, Safer-Use Education, and First-Week Safety Workflows

Most diversion models focus on treatment linkage, but the highest mortality risk often sits in the days immediately surrounding justice contact—after release, after court processing, or after a disruption in routine. If harm reduction is not embedded into the diversion workflow, counties inadvertently treat overdose prevention as “someone else’s job” and lose the chance to stabilize people during the most volatile period. Counties with stronger outcomes operationalize overdose prevention the same way they operationalize scheduling: clear roles, defined touchpoints, and auditable completion. This article supports justice-system interfaces and diversion pathway operations and aligns with community-based SUD service models that can carry people through the first week without relying on luck or informal workarounds.

Why overdose prevention is a diversion infrastructure requirement

Diversion participants can be clinically “eligible” and still be at acute risk: reduced tolerance after short custody stays, polysubstance exposure, fentanyl-adulterated supply, unstable housing, and disrupted social supports. Even when treatment appointments are scheduled, a single gap—missed first visit, delayed medication start, no transport, unreachable phone—can become an overdose event before the pathway has a chance to engage. Embedding overdose prevention reduces the consequences of inevitable early instability.

Operationally, this means counties define a minimum safety bundle that must be completed before a person leaves the diversion touchpoint and a first-week follow-up sequence that treats “no contact” as a risk signal, not a passive outcome.

Oversight and funder expectations that shape overdose prevention in diversion

Expectation 1: Evidence of risk mitigation, not just referrals. Counties are often expected to demonstrate that diversion reduces preventable harm and uses public resources responsibly. Programs that only report “referrals made” struggle to show they managed the highest-risk window. A defensible approach documents completion of overdose education, naloxone provision, and follow-up actions after missed contacts.

Expectation 2: Standardized practice that supports equity and consistent delivery. Oversight bodies commonly scrutinize whether safety supports are provided consistently across courtrooms, shifts, and agencies. When naloxone and education are dependent on individual staff enthusiasm, delivery becomes uneven. Standardization protects equity and reduces reputational and liability exposure after adverse events.

Operational Example 1: “Safety bundle” completion at the diversion decision point

What happens in day-to-day delivery. Before the person leaves court, a station-based deflection site, or a release planning encounter, staff complete a short safety bundle with a defined checklist and documentation step. The bundle typically includes: overdose education tailored to current risk (recent abstinence, mixing substances, using alone), naloxone provision with hands-on demonstration, and a brief safer-use plan (where will the person be tonight, who can respond, what is the plan if cravings or withdrawal escalate). Staff record completion in the diversion tracking system and provide a simple printed safety card with key steps and the program’s follow-up contact method. If the person refuses elements, refusal is documented and a re-offer is built into the first-week outreach plan.

Why the practice exists (failure mode it addresses). Diversion programs often assume that “treatment referral” equals risk reduction. In reality, treatment starts may be delayed and clients may return to use in the interim. The safety bundle exists to reduce harm during the gap between decision and stabilization, especially when tolerance has changed or supply is unpredictable.

What goes wrong if it is absent. People leave the diversion touchpoint with an appointment they may not attend and no immediate overdose protection. Staff later discover they could not make contact, the phone number was inactive, or the client never reached the provider. The next system touchpoint becomes an EMS response, ED visit, or death investigation—outcomes that are both preventable and reputationally catastrophic for diversion credibility.

What observable outcome it produces. Counties can measure and audit safety-bundle completion rates, naloxone distribution counts linked to diversion participants, and reductions in early crisis escalations. Documentation provides defensible evidence that the county offered and delivered concrete risk mitigation rather than relying on post-event explanations.

Operational Example 2: Naloxone supply chain and “always available” distribution workflow

What happens in day-to-day delivery. Counties treat naloxone availability as a supply chain problem, not a last-minute request. The diversion program maintains a standing inventory at distribution points (court program office, deflection hubs, reentry coordinators, partner providers) with reorder thresholds, a designated inventory owner, and monthly reconciliation. Staff are trained to distribute consistently, document lot numbers where required, and provide brief education in a standard format. The workflow includes a back-up plan for stockouts (rapid transfer from another site, expedited resupply, or referral to a confirmed community distribution partner the same day).

Why the practice exists (failure mode it addresses). Many programs “intend” to provide naloxone but fail operationally due to stockouts, unclear ownership, or inconsistent documentation. The supply workflow exists to prevent the most basic failure mode: staff want to provide a kit but cannot, or provide one without training and documentation, undermining accountability.

What goes wrong if it is absent. Distribution becomes opportunistic and uneven. Some participants receive multiple kits while others receive none, depending on location and staff familiarity. Stockouts create avoidable gaps, and programs cannot defend their claims because they cannot show where kits went, whether education occurred, or whether distribution matched risk patterns.

What observable outcome it produces. Programs can evidence reliable availability (low stockout rates), consistent distribution across touchpoints, and improved completion of documented education. Over time, the system can align distribution with risk stratification (recent custody release, prior overdose, polysubstance use), demonstrating intelligent targeting rather than random provision.

Operational Example 3: First-week safety follow-up with escalation that stays supportive

What happens in day-to-day delivery. The diversion pathway assigns first-week safety follow-up to a named role (peer navigator, care coordinator, or outreach clinician). Follow-up includes scheduled contacts at day 1–2 and day 5–7 to confirm: the person is alive and reachable, the naloxone kit is still in hand, the treatment plan remains viable, and immediate risks have not escalated (new housing instability, relapse, severe withdrawal, suicidality). If the person misses the first treatment appointment, the protocol triggers same-day outreach and a barrier/risk review, with supportive escalation options such as mobile outreach, rapid rescheduling into protected slots, or connection to stabilization services when outpatient engagement is not safe. Supervisors audit a sample of “no contact” cases monthly to confirm that escalation followed protocol and did not drift into punitive enforcement.

Why the practice exists (failure mode it addresses). Early disengagement is common and dangerous. Without proactive follow-up, the system learns about failure only when an overdose or re-arrest occurs. The first-week protocol exists to convert missed contact into actionable outreach, reducing the chance that clients disappear during the most lethal window.

What goes wrong if it is absent. Programs classify missed appointments as client choice and move on, while risk accumulates invisibly. Courts tighten conditions in response to perceived “noncompliance,” and providers lose confidence that diversion referrals will stay engaged. The pathway becomes a churn engine, not a safety intervention.

What observable outcome it produces. Counties can measure first-week contact completion, re-engagement after missed starts, and reductions in early unplanned crisis contacts. Case reviews become constructive: they identify process failures (wrong phone number, transport gap, missed risk flag) and produce corrective actions that improve safety over time.

Making overdose prevention measurable without turning it into surveillance

  • Define completion events: safety bundle completed, kit provided, first-week contacts attempted and completed.
  • Separate support from enforcement: ensure safety follow-up does not become a compliance trap.
  • Use learning loops: review overdoses and near-misses as system improvement opportunities, not blame exercises.
  • Report equity: monitor whether safety supports are delivered consistently across locations and populations.

Overdose prevention in diversion succeeds when it is operationalized as infrastructure: a standard safety bundle, reliable naloxone supply, and first-week follow-up that treats “no contact” as a solvable risk problem. Done well, counties reduce preventable harm while building the audit trail and governance discipline needed to sustain funding and trust.